genOway Société anonyme reported earnings results for the half year ended June 30, 2022. For the half year, the company reported revenue was EUR 7.76 million compared to EUR 6.18 million a year ago. Net income was EUR 0.201 million compared to net loss of EUR 0.676 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 EUR | +0.24% | +2.43% | -8.26% |
2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
2023 | GENOWAY : Euroland initiates buy coverage | CF |
1st Jan change | Capi. | |
---|---|---|
-8.26% | 41.47M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- ALGEN Stock
- News genOway
- GenOway Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022